DK0838473T3 - Peptid til inhibering af blodtriglyceridkoncentrationsstigning og inhibitor for blodtriglycerid-koncentrationsstigning omfattende peptidet som aktiv bestanddel - Google Patents
Peptid til inhibering af blodtriglyceridkoncentrationsstigning og inhibitor for blodtriglycerid-koncentrationsstigning omfattende peptidet som aktiv bestanddelInfo
- Publication number
- DK0838473T3 DK0838473T3 DK96916354T DK96916354T DK0838473T3 DK 0838473 T3 DK0838473 T3 DK 0838473T3 DK 96916354 T DK96916354 T DK 96916354T DK 96916354 T DK96916354 T DK 96916354T DK 0838473 T3 DK0838473 T3 DK 0838473T3
- Authority
- DK
- Denmark
- Prior art keywords
- peptide
- concentration increase
- blood triglyceride
- triglyceride concentration
- blood
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Obesity (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Child & Adolescent Psychology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Peptides Or Proteins (AREA)
- Fodder In General (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8066916A JP2805194B2 (ja) | 1996-03-22 | 1996-03-22 | 血中トリグリセリド濃度上昇抑制ペプチド及び当該ペプチドを有効成分として含む血中トリグリセリド濃度上昇抑制剤 |
PCT/JP1996/001570 WO1997035875A1 (fr) | 1996-03-22 | 1996-06-10 | Peptide destine a inhiber l'elevation du taux de triglycerides dans le sang et agent d'inhibition contenant ce peptide en tant qu'ingredient actif |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0838473T3 true DK0838473T3 (da) | 2003-02-17 |
Family
ID=13329785
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK96916354T DK0838473T3 (da) | 1996-03-22 | 1996-06-10 | Peptid til inhibering af blodtriglyceridkoncentrationsstigning og inhibitor for blodtriglycerid-koncentrationsstigning omfattende peptidet som aktiv bestanddel |
Country Status (11)
Country | Link |
---|---|
US (1) | US5958885A (da) |
EP (1) | EP0838473B1 (da) |
JP (1) | JP2805194B2 (da) |
KR (1) | KR100264344B1 (da) |
AT (1) | ATE225803T1 (da) |
AU (1) | AU690853B2 (da) |
CA (1) | CA2221767C (da) |
DK (1) | DK0838473T3 (da) |
ES (1) | ES2184865T3 (da) |
NO (1) | NO325836B1 (da) |
WO (1) | WO1997035875A1 (da) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000095794A (ja) * | 1998-09-22 | 2000-04-04 | Itoham Foods Inc | エンケファリン分解酵素の阻害剤 |
JP2000264845A (ja) * | 1999-02-04 | 2000-09-26 | Nippon Synthetic Chem Ind Co Ltd:The | コレステロール降下剤及びその用途 |
US7060467B2 (en) | 2000-03-13 | 2006-06-13 | Monsanto Technology Llc | Recombinant proteins containing repeating units |
DE10105041A1 (de) * | 2001-02-05 | 2002-08-14 | Tell Pharm Ag Hergiswil | Tripeptide und Tripeptid-Derivate für die Behandlung neurodegenerativer Krankheiten |
US20070254889A1 (en) * | 2001-04-23 | 2007-11-01 | Lee-Way Jin | Compounds and methods useful for rescuing cells from beta-amyloid toxicity and treatment of Alzheimer's disease |
WO2003092614A2 (en) * | 2002-05-02 | 2003-11-13 | Hickle Randall S | Lipid removal from the body |
GB0211849D0 (en) * | 2002-05-23 | 2002-07-03 | Mok Kenneth H | Improvments to retro-inverso isomers |
NO322425B1 (no) * | 2003-07-04 | 2006-10-02 | Berge Biomed As | Anvendelse av et hydrolysat av proteinholdig fiskemateriale for fremstilling av et farmasoytisk middel for behandling og/eller hindring av patologisk hoye nivaer av tracylglyceroler, hyperkolesterolemia, hyperhomocysteinemia, eller patologisk lave nivaer av beta-oksidasjon i et dyr eller menneske. |
WO2006038327A1 (ja) * | 2004-09-30 | 2006-04-13 | Suntory Limited | グロビン蛋白分解物を含有する酵母発酵飲料 |
WO2006052031A1 (en) * | 2004-11-15 | 2006-05-18 | Mg Pharma Inc. | Protein hydrolysate with antidiabetic effect |
JP4395658B2 (ja) | 2005-11-17 | 2010-01-13 | エムジーファーマ株式会社 | コレステロール再上昇抑制用組成物およびその用法 |
JP5175484B2 (ja) * | 2007-03-30 | 2013-04-03 | 名古屋製酪株式会社 | 血中中性脂肪濃度上昇抑制剤 |
CA2695666C (en) * | 2007-08-07 | 2016-05-17 | Mg Pharma Inc. | Anti-hypertensive agent |
WO2018001273A1 (zh) * | 2016-06-30 | 2018-01-04 | 江西本草天工科技有限责任公司 | 肽或其盐、其制备方法、及其制备预防和/或治疗肝损伤药物的用途 |
CN107556363B (zh) * | 2016-06-30 | 2021-03-30 | 江西本草天工科技有限责任公司 | 肽或其盐及其制备方法 |
CN107551258B (zh) * | 2016-06-30 | 2021-01-05 | 江西本草天工科技有限责任公司 | 用于预防和/或治疗肝损伤的vvyp |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5723443A (en) * | 1988-02-02 | 1998-03-03 | Hankyu-Kyoei Bussan Co. Ltd. | Lipid metabolism promoting agent and its use |
CA1335567C (en) * | 1988-02-02 | 1995-05-16 | Kyoichi Kagawa | Lipid metabolism promoting agent |
JP2764276B2 (ja) * | 1988-09-06 | 1998-06-11 | 仙味エキス株式会社 | 機能性新規ペプチド及びその利用 |
JPH0331298A (ja) * | 1989-06-28 | 1991-02-12 | Ajinomoto Co Inc | プロリルエンドペプチターゼ阻害ペプチド |
JPH03120224A (ja) * | 1989-10-04 | 1991-05-22 | Ajinomoto Co Inc | 新規ペプチドおよびこれを含有する降圧剤 |
JP3312944B2 (ja) * | 1993-03-24 | 2002-08-12 | 伊藤ハム株式会社 | 脂肪細胞分化抑制ペプチド及び当該ペプチドを有効成分とする脂肪細胞分化抑制剤 |
JP2800877B2 (ja) * | 1993-12-28 | 1998-09-21 | 伊藤ハム株式会社 | 血中トリグリセリド濃度上昇抑制ペプチド及び当該ペプチドを有効成分として含む血中トリグリセリド濃度上昇抑制剤 |
-
1996
- 1996-03-22 JP JP8066916A patent/JP2805194B2/ja not_active Expired - Lifetime
- 1996-06-10 CA CA002221767A patent/CA2221767C/en not_active Expired - Fee Related
- 1996-06-10 DK DK96916354T patent/DK0838473T3/da active
- 1996-06-10 AT AT96916354T patent/ATE225803T1/de not_active IP Right Cessation
- 1996-06-10 US US08/973,539 patent/US5958885A/en not_active Expired - Lifetime
- 1996-06-10 EP EP96916354A patent/EP0838473B1/en not_active Expired - Lifetime
- 1996-06-10 KR KR1019970708355A patent/KR100264344B1/ko not_active IP Right Cessation
- 1996-06-10 AU AU59120/96A patent/AU690853B2/en not_active Ceased
- 1996-06-10 WO PCT/JP1996/001570 patent/WO1997035875A1/ja active IP Right Grant
- 1996-06-10 ES ES96916354T patent/ES2184865T3/es not_active Expired - Lifetime
-
1997
- 1997-11-21 NO NO19975360A patent/NO325836B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0838473A1 (en) | 1998-04-29 |
ATE225803T1 (de) | 2002-10-15 |
AU690853B2 (en) | 1998-04-30 |
AU5912096A (en) | 1997-10-17 |
ES2184865T3 (es) | 2003-04-16 |
NO325836B1 (no) | 2008-07-28 |
US5958885A (en) | 1999-09-28 |
WO1997035875A1 (fr) | 1997-10-02 |
NO975360L (no) | 1998-01-21 |
CA2221767C (en) | 2001-01-23 |
JP2805194B2 (ja) | 1998-09-30 |
EP0838473A4 (en) | 2000-04-05 |
CA2221767A1 (en) | 1997-10-02 |
NO975360D0 (no) | 1997-11-21 |
KR100264344B1 (ko) | 2000-08-16 |
KR19990021880A (ko) | 1999-03-25 |
JPH09255698A (ja) | 1997-09-30 |
EP0838473B1 (en) | 2002-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0838473T3 (da) | Peptid til inhibering af blodtriglyceridkoncentrationsstigning og inhibitor for blodtriglycerid-koncentrationsstigning omfattende peptidet som aktiv bestanddel | |
ES2153415T3 (es) | Peptido inhibidor de la diferenciacion de adipocitos e inhibidor de la diferenciacion de adipocitos que contiene dicho peptido como ingrediente activo. | |
DE60305055D1 (de) | Verwendung von ghrelin zur behandlung von unterernährung von gastrektomiepatienten | |
DE60126829D1 (de) | Kombination von drei Substanzen zur Vorbeugung und Behandlung von Arthritis | |
DK1599215T3 (da) | Anvendelse af tryptophanrige peptider fra mælkeproteinhydrolysat til behandling af overvægt og fedme | |
Croom et al. | Neuropeptide Y, peptide YY and aluminum in Alzheimer’s disease:: Is there an etiological relationship? | |
DE69735883D1 (de) | Methode zur behandlung von muskelkrankheiten | |
ATE183651T1 (de) | Verwendung von wachstumsfaktor igf-ii zur beahandlung von gastrointestinalen störungen | |
DE69129267T2 (de) | Methode zur behandlung intestinaler krankheiten | |
DK0838474T3 (da) | Peptid som inhiberer blodtriglyceridstigning og blodtriglyceridstigningsinhibitor indeholdende nævnte peptid som aktiv ingrediens | |
ATE108063T1 (de) | Heilmittel zur behandlung von toxoplasmose. | |
DE69030732D1 (de) | Antiparasitäre zusammensetzung zur verwendung bei tieren | |
ATE107504T1 (de) | Arzneimittel zur behandlung von kryptosporidiose. | |
CA2225412A1 (en) | A peptide inhibiting elevations of triglyceride levels in blood and an agent for inhibiting elevations of triglyceride levels in blood comprising the peptide as an active component | |
EA199700019A1 (ru) | Способ увеличения прироста цыплят | |
Shivaprakash et al. | Incidence and management of congenital malformations of muscular system and limbs | |
WO2003096964A3 (en) | Means for use in treating diseases correlated with or caused by non-physiological levels of microtubule-associated pp2ac | |
ATE218869T1 (de) | Verfahren zur behandlung von lebererkrankungen und ähnlichen indikationen mit vasodilatierenden wirkstoffen | |
RU97120642A (ru) | Способ лечения заболеваний и повреждений плюсневых костей при тотальном дефекте |